
FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults …
Read More